Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 3

Drawing

Generic Name
Brand Name
Classification
Action
Dosage

Cefazolin
Fonvicol
Therapeutic: anti-infectives
Pharmacologic: first-generation cephalosporins
Binds to bacterial cell membranes, inhibits cell wall synthesis.
Therapeutic Effect: Bactericidal
1gm IV q8
Skin and skin structure infections (including burn wounds)
Pneumonia
UTI
Bone and joint infections

Indication

Septicemia
Perioperative prophylaxis
Biliary tract infections
Genital infections
Bacterial endocarditis prophylaxis for dental

Contraindicatio
n

Upper respiratory tract procedures.


Hypersensitivity to cephalosporins
Serious hypersensitivity to penicillins.

History of GI disease, especially colitis.


Side Effects and Seizures (high doses)

Diarrhea
Nausea
Vomiting
Adverse Effects

Cramps
Rashes
Pruritis
Urticarial

Nursing
Responsibilities

Phlebitis at IV site.
1. Assess for infection (vital signs; appearance of wound, sputum,
urine, and stool; WBC) at beginning and during therapy.
2. Before initiating therapy, obtain a history to determine
previous use of and reactions to penicillins or cephalosporins.
Persons with a negative history of penicillin sensitivity may
still have an allergic response.
3. Obtain specimens for culture and sensitivity before initiating
therapy. First dose may be given before receiving results.
4. Observe patient for signs and symptoms of anaphylaxis (rash,
pruritus, laryngeal edema, wheezing). Discontinue drug and
notify health care professional immediately if these problems
occur. Keep epinephrine, an antihistamine, and resuscitation
equipment close by in case of an anaphylactic reaction.
5. Monitor bowel function. Diarrhea, abdominal cramping, fever,
and bloody stools should be reported to health care
professional promptly as a sign of pseudomembranous colitis.
May begin up to several weeks following cessation of therapy.
6. Assess patient for skin rash frequently during therapy.
Discontinue cephalosporins at first sign of rash; may be life
threatening. Stevens-Johnson syndrome or toxic epidermal
necrolysis may develop. Treat symptomatically; may recur
once treatment is stopped.
7. Lab Test Considerations: May cause positive results for

Coombs test in patients receiving high doses or in neonates


whose mothers were given cephalosporins before delivery.
8. May cause serum AST, ALT, alkaline phosphatase, bilirubin,
LDH, BUN, creatinine.
9. May rarely cause leukopenia, neutropenia, agranulocytosis,

Source

thrombocytopenia, or eosinophilia.
Davis's Drug Guide for Nurses by Deglin, Judith Hopfer, Sanoski,
Cynthia, Vallerand, April, 14th Edition; pages 284-286

You might also like